IMG-20250929-WA0003

A Delegation from the Kurdistan Medical Control Agency Visits New Standard’s Pharmaceutical Laboratory in Erbil

DelegationQuality Control of Medicines and Medical Supplies

A delegation from the Kurdistan Medical Control Agency (KMCA) conducted a field visit to New Standard Company’s pharmaceutical laboratory in Erbil to review ongoing operations and laboratory activities.
The purpose of the visit was to assess the laboratory’s infrastructure and technical procedures, and to verify their compliance with health and quality standards adopted in the Kurdistan Region. The delegation also received a detailed briefing from the technical staff on the testing and control mechanisms applied by the laboratory to ensure the quality and safety of pharmaceutical products.
During the visit, New Standard reaffirmed its full commitment to both local and international standards in quality control and testing, highlighting that the development of laboratories represents a core component of the company’s strategy to build trust in pharmaceutical products and to support the healthcare sector in the region.
This visit comes within the framework of ongoing cooperation and coordination between the public and private sectors, aiming to enhance laboratory services and ensure the availability of safe and high-quality medicines for citizens.

0600

New Standard Launches a Temporary Site of the Laboratory for Quality Control of Medicines and Medical Supplies in Erbil.

Quality Control of Medicines and Medical Supplies

New Standard launched a temporary site of the New Standard Laboratory for Quality Control of Medicines and Medical Supplies in Erbil to ensure uninterrupted service while construction continues on the dedicated branch within the Central Quality Laboratory campus. The interim site features advanced instrumentation from internationally accredited manufacturers and a comprehensive training program for scientific and technical teams.
Harmonized procedures, controlled environments, and robust chain-of-custody will be applied from sample receipt through certified reporting—maintaining turnaround times, traceability, and alignment with international quality standards.

1000

New Standard Signs Official Contract with North Light Living to Build the Central Quality Laboratory in Baharka, Erbil.

Quality Control of Medicines and Medical Supplies

New Standard signed an official contract with North Light Living to construct the company’s Central Quality Laboratory in Baharka, Erbil. The signing took place at New Standard’s headquarters in Erbil and formalizes cooperation to deliver a 13,000 m² campus designed to international standards.
The laboratory will consolidate major testing divisions—including human pharmaceuticals, veterinary medicines, and pesticides—with modern infrastructure that supports full traceability from sample receipt to certified reporting. Completion is targeted for the end of June 2026.

200

Planning and Site Visit for the National Central Warehouses for Medicines in Erbil with Golden Eagle Global (GEG).

Quality Control of Medicines and Medical Supplies

New Standard and Golden Eagle Global (GEG) held a planning session and conducted a field visit to the 60-dunam (≈150,000 m²) site in Erbil. The visit was limited to viewing the site, confirming approximate boundaries and access roads, and noting basic utilities and ground conditions.
The project aims to strengthen the Kurdistan Region’s pharmaceutical supply chain by adding compliant storage capacity in Erbil and enabling faster, traceable distribution to public and private healthcare partners.

1201

Launch of Construction Works for New Standard’s Central Quality Assurance Laboratory in Baharka – Erbil, Covering 13,000 m²

Quality Control of Medicines and Medical Supplies

New Standard has announced the commencement of construction works for its Central Quality Assurance Laboratory in Baharka – Erbil, with an area of 13,000 m² and built to international standards. The project aims to consolidate major testing branches under one roof, including human pharmaceutical analysis, veterinary drug testing, and pesticide evaluation.
The complex will serve as an advanced reference hub for Kurdistan and the wider region, featuring controlled environments and an integrated workflow that ensures efficiency and full traceability from sample receipt to the issuance of certified reports. Completion is expected by the end of June 2026.